Overview

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Status:
Unknown status

Trial end date:
2020-08-01

Target enrollment:

Participant gender:

Summary

This study seeks to investigate whether non-selective beta blocker treatment decreases intestinal permeability in cirrhotic patients by altering the expression of genes encoding intercellular junction proteins.

Phase:

N/A

Details

Lead Sponsor:

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Treatments:

Adrenergic beta-Antagonists
Propranolol